ARTICLE | Clinical News
Cobas EGFR Mutation Test v2 regulatory update
October 10, 2016 7:00 AM UTC
FDA approved a PMA from Roche for a blood-based version of its cobas EGFR Mutation Test v2 as a companion diagnostic for Tagrisso osimertinib from AstraZeneca to treat EGFR T790M mutation-positive, m...